Obagi Medical Products

Content on this page requires a newer version of Adobe Flash Player.

Get Adobe Flash player

Obagi Medical Products ( OMPI) is a specialty pharmaceutical company that develops, markets and sells, and is a provider of, topical aesthetic and therapeutic prescription-strength skin care systems and related products in the physician-dispensed market. This stock is trading up 6.7% at $14.73 in recent trading.

Today's Volume: 484,000

Average Volume: 127,794

Volume % Change: 754%

>>22 Biopharma Stocks With Breakout Potential in 2012

From a technical perspective, OMPI is soaring higher here with monster volume. This move has pushed OMPI into breakout territory since the stock is hitting a new three-year high and taking out its past overhead resistance at $14.28.

Traders should continue to look for long-biased trades as long as OMPI is trending above $14.28 with strong upside volume flows . I would consider any upside volume day that registers near or above 127,794 shares as bullish. If we continue to see that action, then OMPI could easily hit $17 to $20 in the near future.

If you liked this article you might like

The Five Dumbest Things on Wall Street: April 12

Merz Withdrawal Frees Obagi-Valeant Merger

Valeant Buys Obagi Medical for $360 Million

Obagi Medical Products Inc. Stock Downgraded (OMPI)

5 Hated Stocks Set to Soar on Earnings